ArticleBone marrow transplantation2018

Safety of nintedanib for treatment of fibrotic lung disease after allogeneic hematopoietic stem cell transplantation.

Kyle R Brownback et al.PubMed ↗Publisher ↗

No numbers read from the abstract.